Year: 2025
Type: article
Abstract: Recent studies continue to support the efficacy and cost-effectiveness of short-term psychodynamic therapies, including ISTDP. A 2023 study replicated ISTDP’s effectiveness for treatment-resistant depression, while pilot trials explored its potential for histrionic and antisocial personality disorders. Research also links therapist oxytocin levels to treatment outcomes. Large-scale studies confirm the societal cost-effectiveness of short-term therapies, while evidence suggests longer treatments yield greater benefits. An umbrella review further establishes psychodynamic therapy as an empirically-supported treatment across mental health conditions.
Source: Journal of Contemporary ISTDP
DOI: 10.70839/0nb0t825
Author: Thomas Hesslow
Language: English
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W4411148349
FWCI:
Cites:
Cited by:
Related to: